Genfit
Manufacturing · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Parc Eurasanté 885 Avenue Eugène Avinée,...Phone Number
+33 320164000Website
www.genfit.comRevenue
$28.6 MillionStock Symbol
GNFTIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Genfit
Genfit, founded in 1999 and headquartered in Loos Hauts-de-France, is a bio-pharmaceutical company that develops therapeutic, and diagnostic solutions to meet needs in the field of metabolic and inflammatory disease.Explore more
Genfit Org Chart
BE
Chief Technology Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Genfit your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Genfit has new funding data
Click to see if Genfit had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Genfit
Genfit, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Genfit recently announced quarterly report
Check if Genfit has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Genfit is spiking on competitors!
Product Launch: Get notified when Genfit launches new products
Recommended Actions
Find VP level buyers at Genfit
Find 3 more new buyers
Company Profile Activity
Activity Insights
Genfit is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Genfit is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Genfit.
Genfit financials insights
Gather financial insights about Genfit, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Share Placement
$15.5M
2014
Share Placement
$5.4M
Share Placement
$22.7M
2016
Share Placement
$36.6M
Share Placement
$48.2M
2017
Debt
$194.5M
2019
Stock Offering
$155.4M
2021
Debt
$13.3M
2025
Debt
$200M
Genfit Tech Stack
A closer look at the technologies used by Genfit
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
New Hire
Executive Move
Executive Moves, New Hire
Person-Based
Person-Based
Genfit News & Media
GENFIT: Positive Phase 1b Data with GNS561 in Combination Therapy in Heavily Pretreated Patients with Cholangiocarcinoma
GENFIT today announced positive Phase 1b results for GNS561 in combination therapy in patients with heavily pretreated cholangiocarcinomaGENFIT: June 15, 2026 Combined Shareholders Meeting Results
GENFIT announces the results of the Combined Shareholders Meeting which took place on June 15, 2026.GENFIT: NASHnext®, Powered by GENFIT's Non-invasive Diagnostic Technology NIS4®, Launched via Labcorp’s OnDemand Offering for Identification of At-Risk MASH
Access to Labcorp’s NASHnext® is now available through Labcorp OnDemand
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Genfit
Sign Up For FreeTo access detailed company insights
Genfit, founded in 1999 and headquartered in Loos Hauts-de-France, is a bio-pharmaceutical company that develops therapeutic, and diagnostic solutions to meet needs in the field of metabolic and inflammatory disease.... Read More
